Features
Get A Demo
Plans
Sign Up
Login
All Federal Grant Programs
Research Related to Deafness and Communication Disorders
Posted
8/22/18
Assistance Listing Number
93.173
Overview
Grant Opportunities
3
Grant Awards
Federal Agency
National Institutes of Health
Applicant Types
Not listed
Beneficiary Types
Not listed
Additional Information
Not listed
Popular Federal Grant Opportunities
Not listed
Popular Federal Grant Awards
Not listed
Name
Description
Solicitation Number
Federal Agency
Due Date
(Click to sort descending)
Posted Date
(Click to sort descending)
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
The purpose of the NIH Research Conference Grant (R13) is to support high quality conferences that are relevant to the public health and to the scientific mission of the participating Institutes and Centers.
PA-20-207
Department of Health and Human Services National Institutes of Health
2/10/21
5/8/20
Limited Competition: Data Analysis and Sharing Center (DASC) for the MACS/WIHS Combined Cohort Study (MWCCS) (U01 Clinical Trials Not Allowed)
This Notice of Funding Opportunity (NOFO) seeks applications to fund a single Data Analysis and Sharing Center (DASC) for the MACS/WIHS Combined Cohort Study (MWCCS), a 7-year epidemiological study of approximately 5,500 middle-aged and older people living with and without HIV across the United States. The funding opportunity is issued by the Department of Health and Human Services National Institutes of Health and is limited to institutions previously funded under RFA-HL-19-007. The study will utilize a populomics approach to examine health determinants across multiple scales of influence, from molecular to sociopolitical levels. The application deadline is May 2, 2025. The NOFO does not specify an exact award value, but previous grants under the associated federal programs have ranged from approximately $35,000 to over $2 million, with typical project periods spanning 2-5 years. The research is expected to be conducted at the recipient organization's facilities across the United States.
RFA-HL-26-010
Department of Health and Human Services National Institutes of Health
5/2/25
1/16/25
PHS 2021-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
Forecast - This Notice is to inform the eligible United States small business concerns of the reissuance of the Omnibus Solicitations of the NIH, CDC and FDA for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grant applications. When reissued, these FOAs will continue to utilize the R41/R42 and R43/44 grant mechanisms. Modifications to these FOAs will be the inclusion of new and revised research priorities. NIH, CDC, and FDA Institutes and Centers likely to participate in one or more of the FOAs include the following: National Institutes of Health (NIH) National Cancer Institute (NCI) National Eye Institute (NEI) National Heart, Lung, and Blood Institute (NHLBI) National Human Genome Research Institute (NHGRI) National Institute on Aging (NIA) National Institute on Alcohol Abuse and Alcoholism (NIAAA) National Institute of Allergy and Infectious Diseases (NIAID) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) National Institute of Biomedical Imaging and Bioengineering (NIBIB) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) National Institute on Deafness and Other Communication Disorders (NIDCD) National Institute of Dental and Craniofacial Research (NIDCR) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) National Institute on Drug Abuse (NIDA) National Institute of Environmental Health Sciences (NIEHS) National Institute of General Medical Sciences (NIGMS) National Institute of Mental Health (NIMH) National Institute of Neurological Disorders and Stroke (NINDS) National Institute of Nursing Research (NINR) National Institute on Minority Health and Health Disparities (NIMHD) National Library of Medicine (NLM) National Center for Complementary and Integrative Health (NCCIH) National Center for Advancing Translational Sciences (NCATS) Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs (ORIP) Centers for Disease Control (CDC) Center for Global Health (CGH/CDC) National Center on Birth Defects and Developmental Disabilities (NCBDDD/CDC) National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP/CDC) National Center for Emerging and Zoonotic Infectious Diseases (NCEZID/CDC) National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP/CDC) National Center for Immunization and Respiratory Diseases (NCIRD/CDC) National Center for Injury Prevention and Control (NCIPC/CDC) National Institute for Occupational Safety and Health (NIOSH/CDC) National Center for Environmental Health (NCEH/CDC) Center for Preparedness and Response (CPR/CDC) Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER/FDA) Center for Drug Evaluation and Research (CDER/FDA) Center for Food Safety and Applied Nutrition (CFSAN/FDA) Center for Devices and Radiological Health (CDRH/FDA) Center for Veterinary Medicine (CVM/FDA) Office of Critical Path Programs (CPI/FDA) Office of Orphan Products Development (OOPD/FDA) This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and appropriate projects. The FOA is expected to be published in Spring 2020 with an expected application due date in Summer 2020.
PA-21-260
Department of Health and Human Services National Institutes of Health
4/5/22
4/6/21